XIth Conference on South Asian Regional Association of Dermatologists
Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON)
ABSTRACT SUBMISSION IS CLOSED NOW.
GUIDELINES FOR ABSTRACT SUBMISSION
All abstract must be sent to the conference through the website www.sarcd2019.com.
RULES FOR ABSTRACT SUBMISSION
a. All abstracts must be the original, unpublished work of the authors, with all listed authors (maximum six) having significant contribution to the completion of the work.
b. The paper should not have been presented in any conference earlier and should not be identical to any abstract submitted elsewhere.
c. Authors are required to indicate their preference for either oral or poster presentation.
d. The scientific sub- committee will make the final decision on the type of presentation (i.e. oral or poster). Notification of acceptance or rejection of the abstracts and further details on presentation will be mailed to the corresponding author. The committee's decision is final.
e. Accepted abstracts will be given instruction on the preparation of posters and information about projection.
f. Submission of an abstract indicates:
ʘ that the author(s) agree to comply with the abstract submission and presentation rules;
ʘ that the presentation is based on scientific and/or clinical methods that are ethical and true;
ʘ that all authors have contributed to and approve the abstract and its entire contents.
g. All accepted abstracts will be published electronically and distributed freely to all delegates.
h. All accepted abstracts will be published electronically and distributed freely to all delegates.
i. Accepted abstracts are official communications of the conference. The presenting author agrees to register, to attend the conference, and to present the abstract as scheduled by the sub- committee.
INSTRUCTIONS FOR ABSTRACT PREPARATION
a. Abstracts must include sufficient information for reviewers to judge the nature and significance of the topic, the adequacy of the investigative strategy, the nature of the results, and the conclusions. The abstract should summarize the substantive results of the work and not merely list topics to be discussed
b. The abstract should include title, author's names, author's affiliation and presenting author.
ʘ Title: Use a concise descriptive title that indicates the content of the abstract. Do not use abbreviation in the title.
ʘ Author: List each author as Surname followed by Initials. Do not use titles, degrees or position. Use comma between authors name. Do not use all capital letters for author's names.
ʘ Affiliations: Each author should be listed by department, institution, city, and country.
c. The abstract must be written and presented in English and should not exceed 250 words (introduction to conclusions), formatted in Microsoft Word, text justification, and single-spaced, using size 12 Times New Roman font. The abstracts which do not meet these criteria will be asked for revisions
d. If the title includes scientific notation, Greek letters, bold, italics, or other special characters/symbols, do make sure they appear correctly
e. The body of the abstract text must be formatted with the following subheadings as appropriate. Standard abbreviations may be used but must be written in full at first use. Propriety names of drugs are not allowed.
f. For the purpose of uniformity, the abstract should be constructed in similar manner provided below.
@For clinical or investigative studies:
ʘ Materials and Methods:
@ For case reports or case series:
g. Note: No tables, references or images are allowed in the abstract.
h. All co-authors must agree with the submitted results and conclusions, and consent to being listed as authors.
i. Work involving humans or animals, or material derived from them must have been approved by an institutional ethics committee.
j. Please send in a brief biography together with the Abstract.
For reviewing and scheduling purposes, abstracts will be classified into different categories. Please indicate on the submission webpage the appropriate topic classifications to which your abstract belongs. Only 1 category may be chosen.
ʘ Acne, rosacea, and related disorders (including hidradenitis suppurativa)
ʘ Adverse drug reactions, including SJS, TEN
ʘ Aesthetic and cosmetic dermatology
ʘ Dermatitis and Dermatoses
ʘ Dermatology: Therapies & Advances
ʘ Dermatology education systems and ethics
ʘ Dermatological surgery
ʘ Diagnostic Techniques in Dermatology
ʘ Hair & Nail disorders
ʘ Infectious diseases (bacterial, fungal, viral, parasitic, infestations)
ʘ Paediatric Dermatology
ʘ Pigmentary Disorders (Vitiligo, melasma, periorbital melanosis, other hyper and hypopigmentations)
ʘ Sexually transmitted infections, HIV/AIDS
Authors will be notified starting from 15th September, 2019 as to the acceptance status of their submissions. This includes the assignment of session category and presentation format (oral or poster).
ʘ The confirmation will be sent by email to the e-mail address supplied by the author in the electronic submission
Detailed instructions regarding requirements and instructions for oral and poster presentations will also be provided at that time.
ABSTRACT SUBMISSION IS CLOSED NOW.